JP2008537958A5 - - Google Patents

Download PDF

Info

Publication number
JP2008537958A5
JP2008537958A5 JP2008506722A JP2008506722A JP2008537958A5 JP 2008537958 A5 JP2008537958 A5 JP 2008537958A5 JP 2008506722 A JP2008506722 A JP 2008506722A JP 2008506722 A JP2008506722 A JP 2008506722A JP 2008537958 A5 JP2008537958 A5 JP 2008537958A5
Authority
JP
Japan
Prior art keywords
polypeptide
wisp
domain
cancer cells
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008506722A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008537958A (ja
JP4979684B2 (ja
Filing date
Publication date
Priority claimed from US11/105,876 external-priority patent/US7455834B2/en
Application filed filed Critical
Publication of JP2008537958A publication Critical patent/JP2008537958A/ja
Publication of JP2008537958A5 publication Critical patent/JP2008537958A5/ja
Application granted granted Critical
Publication of JP4979684B2 publication Critical patent/JP4979684B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2008506722A 2005-04-14 2006-04-13 Wisp活性を調節し検出するための方法及び組成物 Expired - Lifetime JP4979684B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/105,876 US7455834B2 (en) 2002-06-29 2005-04-14 Methods and compositions for modulating and detecting WISP activity
US11/105,876 2005-04-14
PCT/US2006/014008 WO2006113402A1 (en) 2005-04-14 2006-04-13 Methods and compositions for modulating and detecting wisp activity

Publications (3)

Publication Number Publication Date
JP2008537958A JP2008537958A (ja) 2008-10-02
JP2008537958A5 true JP2008537958A5 (cg-RX-API-DMAC7.html) 2009-05-28
JP4979684B2 JP4979684B2 (ja) 2012-07-18

Family

ID=36809580

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008506722A Expired - Lifetime JP4979684B2 (ja) 2005-04-14 2006-04-13 Wisp活性を調節し検出するための方法及び組成物

Country Status (16)

Country Link
US (2) US7455834B2 (cg-RX-API-DMAC7.html)
EP (1) EP1869086B1 (cg-RX-API-DMAC7.html)
JP (1) JP4979684B2 (cg-RX-API-DMAC7.html)
KR (1) KR101320261B1 (cg-RX-API-DMAC7.html)
CN (1) CN101198623B (cg-RX-API-DMAC7.html)
AU (1) AU2006236649B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0612184A8 (cg-RX-API-DMAC7.html)
CA (1) CA2604933C (cg-RX-API-DMAC7.html)
ES (1) ES2388993T3 (cg-RX-API-DMAC7.html)
IL (1) IL186095A (cg-RX-API-DMAC7.html)
MX (1) MX2007012798A (cg-RX-API-DMAC7.html)
NO (1) NO20075825L (cg-RX-API-DMAC7.html)
NZ (1) NZ561709A (cg-RX-API-DMAC7.html)
RU (1) RU2412201C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006113402A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200708738B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7455834B2 (en) * 2002-06-29 2008-11-25 Genentech, Inc. Methods and compositions for modulating and detecting WISP activity
BR112014019741A2 (pt) 2012-02-11 2020-12-22 Genentech, Inc Usos de um antagonista da via wnt, uso de uma terapia anticâncer, método de identificação de um indivíduo com câncer, métodos para prever, método de inibição da proliferação de uma célula de câncer, uso de um antagonista da translocação de r-spondina e antagonista da translocação de r-spondina isolado
KR20150134346A (ko) * 2013-03-27 2015-12-01 지이 헬스케어 에이에스 진단 조성물을 제조하기 위한 방법 및 시약
CN106456732A (zh) * 2014-04-15 2017-02-22 索伦托治疗有限公司 结合wisp1的抗体疗法
KR102011366B1 (ko) * 2016-11-17 2019-10-14 연세대학교 산학협력단 암 전이 억제제의 스크리닝 방법
EP4365299A3 (en) * 2018-05-17 2024-08-07 Olives Biotherapeutics Inc. Pharmaceutical composition comprising ccn5 as active ingredient for preventing or treating retinal disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
ATE406441T1 (de) 1997-10-29 2008-09-15 Genentech Inc Verwendung des wnt-1 induzierten sekretierten polypeptids wisp-1
PT1623990E (pt) 1999-03-08 2008-03-18 Genentech Inc Composições e métodos para o tratamento de tumores
JP4636497B2 (ja) 2002-06-29 2011-02-23 ジェネンテック, インコーポレイテッド Wisp活性を調節し検出するための方法及び組成物
US7455834B2 (en) 2002-06-29 2008-11-25 Genentech, Inc. Methods and compositions for modulating and detecting WISP activity
JP2007505131A (ja) 2003-09-11 2007-03-08 ジェネンテック・インコーポレーテッド Wispアンタゴニストの使用方法

Similar Documents

Publication Publication Date Title
HRP20150432T1 (hr) Indentifikacija antigena povezanih s tumorom za dijagnozu i terapiju
RU2012137503A (ru) Лекарственный препарат для лечения и/или профилактики рака
HRP20240495T1 (hr) Anti-garp antitijelo
CY1117031T1 (el) Μονοκλωνικα αντισωματα εναντι claudin-18 στην αγωγη εναντι καρκινου
FI3478723T3 (fi) Pd-l1-spesifisiä vasta-aineita ja niiden käyttömenetelmiä
SI2342234T1 (en) MONOCOLIC ANTI-GT468 CANCER CANCER PROTITEL
RU2013155455A (ru) Антитела для лечения раковых заболеваний, при которых эскспрессируется клаудин 6
RU2013104830A (ru) Лечение рака при помощи направленных на мишень антител in vivo
RU2007136026A (ru) Варианты ил-21
RU2014141151A (ru) Диагностика и лечение злокачественной опухоли с использованием антитела против ereg
RU2017138468A (ru) Антитела против человеческого her3, имеющие низкое содержание фукозы, и области их применения
CA3016333A1 (en) Nanoliposomal targeting of ephrin receptor a2 (epha2) and related diagnostics
RU2016146389A (ru) Улучшенные полиэтилениминовые полиэтиленгликолевые векторы
Choi et al. A phase I study of nimotuzumab in combination with radiotherapy in stages IIB–IV non-small cell lung cancer unsuitable for radical therapy: Korean results
HK1255815A1 (zh) 治疗腹膜癌的组合物和方法
JP2015506961A5 (cg-RX-API-DMAC7.html)
MX2019009121A (es) Antcuerpos anti-kaag1 o fragmento de union al antigeno del mismo para el tratamiento de cancer de mama triple negativo.
MX2022005704A (es) Peptidos antigenicos para la prevencion y el tratamiento de malignidad de celulas b.
HRP20231636T1 (hr) Igg epitop i njegova primjena kao cilja
GB2474807A (en) Vhz for diagnosis and treatment of cancers
ME02725B (me) Inhibitori proteazoma za lećenje kancera
BRPI0707247B8 (pt) vacina para tumor compreendendo células tumorais alogênicas ou xenogênicas
RU2007142005A (ru) Способы и композиции для модуляции и обнаружения активности wisp
Hana et al. Molecular Targeting of the Claudins Pathway.
ES2348161T3 (es) Métodos para dañar células usando funciones efectoras de anticuerpos anti-gfra1.